55 Results for "

PPAR modulators

" in MedChemExpress (MCE) Product Catalog:
Products (55)

55 Results for "PPAR modulators" in MCE Product Catalog:

  • Targets Recommended:
189
189 Publications Verification
Cat. No.: HY-14600
CAS No.: 155141-29-0
Purity:  99.73%
Synonyms: BRL 49653C
Rosiglitazone maleate (BRL 49653C) is a potent and selective activator of PPARγ, with EC50s of 30 nM, 100 nM and 60 nM for PPARγ1, PPARγ2, and PPARγ, respectively, and a Kd of appr 40 nM for PPARγ; Rosiglitazone maleate is also an modulator of TRP channels, inhibits TRP melastatin 2 (TRPM2), TRPM3 and activates TRP canonical 5 (TRPC5).
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-101259
CAS No.: 182135-66-6
Purity:  99.5%
Synonyms: BMS 614
BMS-195614 (BMS 614) is an orally active neutral RARα-selective antagonist with a Ki of 2.5 nM. BMS-195614 restores the expression of Bcl2. BMS-195614 inhibits the transactivation of NF-κB, AP-1 and PPAR. BMS-195614 downregulates the expression of IL-6 and VEGF. BMS-195614 reduces blue light-induced phototoxicity and inhibits cell migration. BMS-195614 modulates inflammation and angiogenesis .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-10863
CAS No.: 94421-68-8
Purity:  ≥98.0%
Synonyms: AEA; Arachidonoyl ethanolamide
Anandamide is an endocannabinoid. Anandamide modulates both neuronal and immune functions through two protein-coupled cannabinoid receptors (CB1 and CB2). Anandamide can activate numerous other receptors like PPARS, TRPV1, and GPR18/GPR55. Anandamide also has potential anti-fungal and anti-inflammatory activities. Anandamide can be used for the research of Alzheimer’s disease (AD) and ulcerative colitis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-108022A
CAS No.: 1314533-27-1
Purity:  99.53%
Synonyms: MSDC-0602K
Target:  

Insulin Receptor PPAR

Research Areas:  

Metabolic Disease

Azemiglitazone potassium (MSDC-0602K), a PPARγ-sparing thiazolidinedione (Ps-TZD), binds to PPARγ with the IC50 of 18.25 μM . Azemiglitazone potassium modulates the mitochondrial pyruvate carrier (MPC). Azemiglitazone potassium can be used for the research of fatty liver including dysfunctional lipid metabolism, inflammation, and insulin resistance . Azemiglitazone potassium, an insulin sensitizer, improves insulinemia and fatty liver disease in mice, alone and in combination with Liraglutide .
loading...
    loading...
Cat. No.: HY-100348
CAS No.: 227947-06-0
Purity:  99.34%
Research Areas:  

Cancer

EPI-001, a selective inhibitor of Androgen Receptor (AR), targets transactivation unit 5 (Tau-5) of the AR. EPI-001 can inhibit transactivation of the AR amino-terminal domain (NTD), with an IC50 of ~6 μM. EPI-001 is also a selective modulator of PPARγ. EPI-001 is active against castration-resistant prostate cancer .
loading...
    loading...
Cat. No.: HY-128400
CAS No.: 959-23-9
Purity:  99.82%
4'-Methoxychalcone regulates adipocyte differentiation through PPARγ activation. 4'-Methoxychalcone modulates the expression and secretion of various adipokines in adipose tissue that are involved in insulin sensitivity .
loading...
    loading...
Cat. No.: HY-101064S3
CAS No.: 1190594-22-9
Purity:  98.90%
Fmoc-leucine-d10 is the deuterium labeled Fmoc-leucine. Fmoc-leucine is a selective PPARγ modulator. Fmoc-leucine activates PPARγ with a lower potency but a similar maximal efficacy than rosiglitazone. Fmoc-leucine improves insulin sensitivity in normal, diet-induced glucose-intolerant, and in diabetic db/db mice. Fmoc-leucine has a lower adipogenic activity .
loading...
    loading...
Cat. No.: HY-134377
CAS No.: 2095128-20-2
Purity:  98.08%
Synonyms: ASP0367; MA-0211
Target:  

PPAR

Research Areas:  

Metabolic Disease

Bocidelpar (ASP0367; MA-0211) is a selective, orally active PPARδ modulator. Bocidelpar activates the PPARδ downstream signaling pathway, upregulates the expression of target genes such as ABCA1 and ACAA2. Bocidelpar then promotes fatty acid oxidation (FAO) and mitochondrial biogenesis, and improves mitochondrial dysfunction. Bocidelpar can improve mitochondrial biogenesis and function in muscle cells. Bocidelpar is mainly used in the study of mitochondrial dysfunction diseases such as primary mitochondrial myopathy (PMM) and Duchenne muscular dystrophy (DMD) .
loading...
    loading...
Cat. No.: HY-100428
CAS No.: 161600-01-7
Purity:  99.88%
Synonyms: MCC-555; Isaglitazone
Target:  

PPAR

Research Areas:  

Metabolic Disease

Netoglitazone (MCC-555) is an orally active PPARγ ligand with an EC50 of 8 μM. Netoglitazone mediates cell type-specific functional regulation, and modulates the transcriptional activity of PPARγ as a full agonist, partial agonist or antagonist. Netoglitazone induces adipogenesis, inhibits osteoblastogenesis, alters the weight of extramedullary fat depots and enhances insulin sensitivity. Netoglitazone reduces blood glucose levels. Netoglitazone can be used in research related to type 2 diabetes and non-insulin-dependent diabetes mellitus .
loading...
    loading...
Cat. No.: HY-117103
CAS No.: 315224-26-1
Purity:  99.64%
Synonyms: INT131
Target:  

PPAR

Research Areas:  

Metabolic Disease

AMG131 (INT131) is a potent non-thiazolidinedione (TZD) selective peroxisome proliferator-activated receptor γ modulator (SPPARM). AMG131 binds to PPARγ within the same binding pocket as the TZDs, but occupies a unique space in the pocket and contacts the receptor at distinct points from the TZDs. AMG131 is promising for research of type-2 diabetes mellitus .
loading...
    loading...
Cat. No.: HY-12557
CAS No.: 2746-34-1
Purity:  99.73%
Synonyms: γ-Glu-Val
γ‑Glutamylvaline (γ-Glu-Val) is a calcium‑sensing receptor (CaSR) agonist. γ‑Glutamylvaline activates CaSR and facilitates its binding to β‑arrestin 2 to modulate inflammatory and metabolic homeostasis signaling. γ‑Glutamylvaline inhibits TNF‑α‑induced IL‑6/MCP‑1 and enhances adiponectin/PPARγ in adipocytes. γ‑Glutamylvaline upregulates Wnt5a, restores β‑catenin phosphorylation, and reduces serine‑phosphorylated IRS‑1 in adipocytes. γ-Glutamylvaline can be used for the research of low-grade chronic inflammation .
loading...
    loading...
Cat. No.: HY-108523
CAS No.: 180713-37-5
Purity:  ≥99.0%
Synonyms: UVI 2112
Target:  

RAR/RXR

Research Areas:  

Metabolic Disease

LG100754 (UVI 2112) is a RXR dimers modulater. LG100754 acts as a RXR:RXR homodimer antagonist, but functions as a agonist towards RXR:PPARα and RXR:PPARγ heterodimers. LG100754 is an insulin sensitizer that functions through RXR .
loading...
    loading...
Cat. No.: HY-101064S2
CAS No.: 538372-74-6
Purity:  98.50%
Synonyms: N-FMOC-leucine-d3; NPC 15199-d3; NSC 334290-d3
Fmoc-leucine-d3 is the deuterium labeled Fmoc-leucine. Fmoc-leucine is a selective PPARγ modulator. Fmoc-leucine activates PPARγ with a lower potency but a similar maximal efficacy than rosiglitazone. Fmoc-leucine improves insulin sensitivity in normal, diet-induced glucose-intolerant, and in diabetic db/db mice. Fmoc-leucine has a lower adipogenic activity .
loading...
    loading...
Cat. No.: HY-116247
CAS No.: 1356497-91-0
Purity:  99.88%
Target:  

PPAR

ST247 a potent PPARβ/δ inverse agonist. ST247 has a higher affinity to PPARβ/δ. ST247 modulates expression of the activation marker CCL2 in the opposite direction. ST247 efficiently induces the interaction with corepressors. ST247 inhibits the agonist-induced transcriptional activity of PPARβ/δ .
loading...
    loading...
Cat. No.: HY-101064S1
CAS No.: 1163133-36-5
Fmoc-leucine- 13C6, 15N is a 15N-labeled and 13C-labled Fmoc-leucine. Fmoc-leucine is a selective PPARγ modulator. Fmoc-leucine activates PPARγ with a lower potency but a similar maximal efficacy than rosiglitazone. Fmoc-leucine improves insulin sensitivity
loading...
    loading...
Cat. No.: HY-10863S
CAS No.: 924894-98-4
Synonyms: AEA-d8
Anandamide-d8 is a deuterated labeled Anandamide . Anandamide is an endocannabinoid. Anandamide modulates both neuronal and immune functions through two protein-coupled cannabinoid receptors (CB1 and CB2). Anandamide can activate numerous other receptors like PPARS, TRPV1, and GPR18/GPR55. Anandamide also has potential anti-fungal and anti-inflammatory activities. Anandamide can be used for the research of Alzheimer’s disease (AD) and ulcerative colitis .
loading...
    loading...
Cat. No.: HY-101746
CAS No.: 1010412-80-2
Purity:  99.06%
Target:  

PPAR

Research Areas:  

Metabolic Disease

GSK376501A is a selective peroxisome proliferator-activated receptor gamma (PPARγ) modulator for the treatment of type 2 diabetes mellitus .
loading...
    loading...
Cat. No.: HY-114739
CAS No.: 2095128-17-7
Purity:  99.31%
Target:  

PPAR

Research Areas:  

Metabolic Disease

MA-0204 is a potent, highly selective and orally available peroxisome proliferator activated receptor δ (PPARδ) modulator with EC50s of 0.4 nM, 7.9 nM and 10 nM for human, mouse and rat PPARδ, respectively. Potential treatment for Duchene Muscular Dystrophy (DMD) .
loading...
    loading...
Cat. No.: HY-101292
CAS No.: 193012-35-0
Purity:  99.97%
Target:  

PPAR

Research Areas:  

Metabolic Disease

FK614 is an orally active, non-thiazolidinedione (TZD) type, and selective PPARγ modulator (SPPARM). FK614 functions as a PPARγ agonist with potent anti-diabetic activity in vivo. FK614 has different effects on the activation of PPARγ at each stage of adipocyte differentiation. FK614 can be used for the research of hyperglycemia, hypertriglyceridemia, glucose intolerance and type 2 diabetes .
loading...
    loading...
Cat. No.: HY-147757
CAS No.: 2089159-00-0
Target:  

PPAR

Research Areas:  

Metabolic Disease

PPARγ/δ modulator 1 (compound 3e) is a potent PPAR modulator. PPARγ/δ modulator 1 is a PPARδ antagonist and a PPARγ partial agonist , with Ki values of 14.4 nM and 5.31 μM, respectively. PPARγ/δ modulator 1 has the EC50 of 7.3 and 12.6 μM for PPARδ corepression and adiponectin production, respectively .
loading...
    loading...